Poster ISLC – The PGE2 Hypothesis: An integrative hypothesis for Long COVID and related syndromes

Skip to content

The PGE2 Hypothesis: An integrative hypothesis for Long COVID and related syndromes

Search for:

Search

Home
- About the authors
Summary hypothesis article
PGE2’s wide-ranging functions
- PGE2 and LC Mechanisms
PGE2 in autoimmunity and resistance
Graphical summaries
- ISLC PAIS Poster
Explainer video
Four LC subphenoptypes
Proposed biomarkers
- Hypothetical EP3-biomarkers
- Gender, steroids and EP3-capacity
Long COVID trials
Potential risks of systemic PGE2 reduction
- On side effects of NSAIDs
Hypothesis testing
- Perspectives of a validated hypothesis

The PGE2 Hypothesis: An integrative hypothesis for Long COVID and related syndromes

Home
- About the authors
Summary hypothesis article
PGE2’s wide-ranging functions
- PGE2 and LC Mechanisms
PGE2 in autoimmunity and resistance
Graphical summaries
- ISLC PAIS Poster
Explainer video
Four LC subphenoptypes
Proposed biomarkers
- Hypothetical EP3-biomarkers
- Gender, steroids and EP3-capacity
Long COVID trials
Potential risks of systemic PGE2 reduction
- On side effects of NSAIDs
Hypothesis testing
- Perspectives of a validated hypothesis

ISLC PAIS Poster

Copyright © 2026 The PGE2 Hypothesis: An integrative hypothesis for Long COVID and related syndromes |Referentie: Ramer, V. & Van Montfrans, G.A. (2026). Persistent prostaglandin E2 upregulation and hormonal multi-resistance: A hypothesis for long COVID. Biochemistry and Biophysics Reports, 46, 102518.

https://www.sciencedirect.com/science/article/pii/S2405580826000786

Scroll to Top